Enhanced apoptosis of soft tissue sarcoma cells with chemotherapy: A potential new approach using TRAIL

Journal of Orthopaedic Surgery

Volumn 9, Issue 2, 2001, Pages 19-22

  Clayer, M ^a   Bouralexixis, S ^a   Evdokiou, A ^a   Hay, S ^a   Atkins, G J ^a   Findlay, D M ^a  

^a QUEEN ELIZABETH HOSPITAL   (Australia)

Author keywords

Apo2L; Chemotherapy; Sarcoma; TRAIL

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; CYTOTOXIC AGENT; DOXORUBICIN; ETOPOSIDE; METHOTREXATE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

APOPTOSIS; ARTICLE; BIOPSY; CANCER COMBINATION CHEMOTHERAPY; CELL CULTURE; CONTROLLED STUDY; DERMATOFIBROMA; DRUG EFFICACY; DRUG MECHANISM; FIBROSARCOMA; HUMAN; HUMAN CELL; HUMAN TISSUE; RHABDOMYOSARCOMA; SARCOMA CELL; SOFT TISSUE SARCOMA;

EID: 0035739542     PISSN: 10225536     EISSN: None     Source Type: Journal    
DOI: 10.1177/230949900100900205     Document Type: Article

References (10)

1. Adjuvant chemotherapy with doxorubicin in high grade soft-tissue: A randomized trial of the Scandinavian Sarcoma Group
2. Safety of antitumor activity of recombinant soluble Apo2 ligand
3. A randomized prospective trial using post-operative chemotherapy (Adriamycin) in high grade extremity soft-tissue sarcoma
4. Intracellular regulation of TRAIL-induced apoptosis in human melanoma cells
5. Chemotherapy augments TRAIL-induced apoptosis in breast cell lines
6. Increased death receptor 5 expression by chemotherapeutic agents in human gliomas causes synergistic cytotoxicity with tumor necrosis factor-related apoptosis-inducing ligand in vitro and in vivo
7. The TNF receptor superfamily of cellular and viral proteins: Activation, co-stimulation, and death
8. Tumoricidal activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo
9. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines